33,467 Shares in Humana Inc. $HUM Purchased by Man Group plc

Man Group plc purchased a new position in shares of Humana Inc. (NYSE:HUM) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 33,467 shares of the insurance provider’s stock, valued at approximately $13,294,000.

Several other large investors also recently bought and sold shares of the business. Montag A & Associates Inc. grew its position in shares of Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in Humana in the 2nd quarter valued at about $26,000. Fideuram Asset Management Ireland dac purchased a new stake in shares of Humana in the 4th quarter valued at approximately $27,000. Trust Co. of Vermont purchased a new stake in Humana in the second quarter valued at approximately $28,000. Finally, Reflection Asset Management acquired a new position in Humana during the 4th quarter worth about $29,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on HUM shares. TD Cowen increased their target price on shares of Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a report on Friday, July 31st. Robert W. Baird set a $390.00 target price on Humana in a research note on Thursday, July 30th. Wolfe Research restated an “outperform” rating and set a $450.00 price target on shares of Humana in a report on Monday. Leerink Partners raised Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price target on the stock in a research report on Thursday, July 30th. Finally, Lake Street Capital started coverage on Humana in a research report on Thursday, July 30th. They set a “buy” rating for the company. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $403.91.

Humana Price Performance

HUM stock opened at $392.72 on Friday. The business has a 50 day moving average price of $385.08 and a 200 day moving average price of $287.78. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The stock has a market cap of $47.16 billion, a price-to-earnings ratio of 37.15, a PEG ratio of 2.23 and a beta of 0.72. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $6.27 EPS. Equities research analysts anticipate that Humana Inc. will post 9.12 earnings per share for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.